SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-410994
Filing Date
2015-12-22
Accepted
2015-12-22 17:14:07
Documents
3
Period of Report
2015-12-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d110447d8k.htm 8-K 20370
2 EX-99.1 d110447dex991.htm EX-99.1 8647
3 GRAPHIC g110447g41q01.jpg GRAPHIC 9074
  Complete submission text file 0001193125-15-410994.txt   42751
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51820 | Film No.: 151302912
SIC: 2834 Pharmaceutical Preparations